Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protease inhibitors are a class of molecules that inhibit the activity of proteases—enzymes responsible for cleaving proteins into smaller, functional units. By blocking these enzymes, protease inhibitors prevent the maturation and replication of viruses or modulate other biological processes involving protein cleavage.
Protease inhibitors bind directly to viral or human proteases, blocking their ability to cleave precursor polyproteins or target proteins. This inhibition prevents the formation of functional proteins and halts viral replication or modulates other biological processes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protease Inhibitor (PI).